Report
EUR 4.00 For Business Accounts Only

Initial View - Presco Plc Q3 2018 - Gains on biological asset flatter earnings

  • Presco released its Q3 18 result late yesterday, wherein it reported 11.7% YoY growth in profit after tax of N4.58 billion (vs N195.6 million loss after tax in the prior year). The impressive Q3 18 performance trimmed plunge in earnings reported over 6M 18 (-21.6% YoY) as cumulative earnings over the nine months period only declined by a tamer 1.5% YoY to N5.28 billion translating to an EPS of N5.28 (vs N5.36 in 9M 17).
  • Revenue Stronger volumes boost revenue: In the review quarter, revenue grew 11.7% YoY to N4.58 billion on the back of higher volumes in the period. According to FEWSNET, local refined Crude palm oil (CPO) prices were down ~20% YoY in Q3 18 following plunge in global CPO prices hence, the revenue growth largely reflects stronger volumes in the period. This is in line with higher volumes reported by Nestle over Q3 18, which is a large off taker of Presco’s refined CPO. This in addition to a 33.6% YoY slump in Cost of sales to N1.2 billion led to gross profit growth of 47.6% YoY to N3.38 billion, translating to gross margin expansion to 73.8% from 55.8% in the prior year.
  • Higher OPEX trim operating profit: Despite expansion in gross profit, Presco’s operating profit for the quarter contacted 19.1% YoY to N1.71 billion in Q3 18. This mirrors higher operating expenses (Q3 18: N1.78 billion vs N358.7 million in Q3 17) in the period following higher Administrative expenses in the period which jumped six-fold to N1.71 billion.
  • Gain on biological asset flatter earnings: However, as against loss on biological asset reported last year (N1.39 billion), Presco reported a N369.6 billion gain on biological asset. Overall, the combination of higher revenues, lower cost of sales and gain on biological asset reported in the period translated to a Profit after tax of N1.29 billion vs a loss after tax of N195.6 million in Q3 17 and an EPS of N1.29. However, after stripping out the volatile biological gains from Presco’s earnings, Profit before tax would have declined 22.1% YoY to N1.38 million over Q3 18.
  • Presco currently trades at a P/E of 8.63x which is at a Premium to 7.62x for Okomu, but discount to 13.5x for MENA peers. We have FVE of N67.47 which represent a 27% upside, hence our  BUY rating on the stock.
  • More analysis to follow.
Provider
ARM Securities Limited
ARM Securities Limited

ARM Securities Limited is a full-service brokerage house that offers best-in-class brokerage services to local as well as foreign private and institutional investors. Formerly known as Hamilton Hammer, the Company commenced operation in 1994 and was acquired by ARM Investment Managers in 2008--an acquisition which has successfully re-positioned the company as a recognized brokerage firm in Nigeria. The Company is a dealing member of the Nigerian Stock Exchange (NSE) and is regulated by Securities and Exchange Commission (SEC). ARM Securities research team provides insightful commentaries on the Nigerian economy and its equity and debt markets using an approach which incorporates a thorough understanding of the fundamentals of the industries and companies under coverage. The research therefore adopts an integrated methodology of top-down analysis and bottom-up stock selection, which focuses on publicly quoted companies on the Nigerian Stock Exchange that are judged to offer the highest potential for earnings growth. In addition, its analysts provide periodic commentaries on a range of topical global and local issues which provide investing clients with a holistic view of the opportunities and risks in today’s financial market landscape. ​

Other Reports from ARM Securities Limited

ResearchPool Subscriptions

Get the most out of your insights

Get in touch